Peripheral arterial disease Circulatory System Peripheral vascular disease, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients intervened percutaneously for treatment or diagnostic of peripheral arterial disease through femoral access in the Department of Angiology and Vascular Surgery of the Hospital Virgen de la Salud de Toledo 2. Aged over 18
Exclusion criteria
Exclusion criteria: 1. Known contraindications for any of the percutaneous arterial closure devices tested 2. Deny of the patient to sign the informed consent document
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effectiveness of the hemostatic procedure applied, assessed by observation of the absence of bleeding through the puncture site immediately after the application of the hemostatic system, 24 hours later and 1 month later | — |
Secondary
| Measure | Time frame |
|---|---|
| Occurrence of complications related to arterial access site, assessed by postprocedure physical examination, echo doppler at the arterial access, and blood test at 24 hours and 1 month post intervention | — |
Countries
Spain